Use of triethylene thio-phosphoramide (thiotepa) in treatment of advanced carcinoma prostate.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D063088:Phosphoramides; D011471:Prostatic Neoplasms; D013852:Thiotepa
D000970:Antineoplastic Agents; D063088:Phosphoramides; C005438:phosphoramide; D013852:Thiotepa
CYTOTOXIC DRUGS/therapeutic use; PROSTATE/neoplasms